---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-072300"
form_type: "8-K"
ticker: null
cik: "0001697532"
company_name: "Applied Therapeutics, Inc."
filed_at: "2023-06-16T23:59:59+00:00"
generated_at: "2026-06-13T22:53:07.601964+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Applied Therapeutics appoints Catherine Thorpe as interim CFO and CAO; Steven Ortega resigns

## Summary
- Steven Ortega resigns as Chief Accounting Officer and Interim Principal Financial Officer effective June 30, 2023, to pursue another opportunity.
- Catherine Thorpe appointed interim Principal Financial Officer and Chief Accounting Officer effective June 16, 2023.
- Thorpe is a CFGI employee; Company entered an engagement letter with CFGI for financial, accounting, and tax services.
- Company to pay CFGI hourly rate for Thorpe's services; fees expected similar to Ortega's compensation.
- No familial relationships with executives; Thorpe to enter standard indemnification agreement.

## SEC filing metadata
- accession: 0001104659-23-072300
- form_type: 8-K
- cik: 0001697532
- company_name: Applied Therapeutics, Inc.
- filed_at: 2023-06-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1697532/000110465923072300/0001104659-23-072300-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1697532/000110465923072300/tm2318933d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-072300
- JSON: https://secwatch.observer/filing/0001104659-23-072300.json
- Plain text: https://secwatch.observer/filing/0001104659-23-072300.txt

## Key facts
- Executive change
  Steven Ortega resigned as Chief Accounting Officer and Interim Principal Financial Officer at Applied Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Accounting Officer and Interim Principal Financial Officer
  source text: On June 14, 2023, Steven Ortega notified Applied Therapeutics, Inc. (the “Company”) that he will resign from his position as the Company’s Chief Accounting Officer and Interim Principal Financial Officer effective as of June 30, 2023, to pursue another professional opportunity.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1697532/000110465923072300/0001104659-23-072300-index.htm
- Executive change
  Catherine Thorpe was appointed as Interim Principal Financial Officer and Chief Accounting Officer at Applied Therapeutics, Inc..
  - Action: appointed
  - Role: Interim Principal Financial Officer and Chief Accounting Officer
  source text: On June 16, 2023, the Company appointed Catherine Thorpe as the interim Principal Financial Officer and Chief Accounting Officer, effective immediately, in light of Mr. Ortega’s anticipated departure and Mr. Ortega ceased to serve in such roles.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1697532/000110465923072300/0001104659-23-072300-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.